Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation-Reference-Cited by-同舟云学术

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation

Published:2021-08-17 Issue:5 Volume:46 Page:695-705
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

O’Jeanson Amaury,Larcher Romaric,Le Souder Cosette,Djebli Nassim,Khier Sonia^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13318-021-00709-w.pdf

Reference43 articles.

1. Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323–9.

2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–10.

3. Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth. 2017;119:626–36.

4. Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys-Silva SA, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis [Internet]. 2018 [cited 2020 Feb 10];5. https://academic.oup.com/ofid/article/5/12/ofy313/5193171.

5. World Health Organization. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI;Antibiotics;2024-08-11

2. Dose rationale for the use of meropenem/vaborbactam combination in paediatric patients with Gram‐negative bacterial infections;British Journal of Clinical Pharmacology;2024-06-26

3. How to use meropenem in pediatric patients undergoing CKRT? Integrated meropenem pharmacokinetic model for critically ill children;Antimicrobial Agents and Chemotherapy;2024-04-24

4. Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study;Acta Anaesthesiologica Scandinavica;2024-01-29

5. Population pharmacokinetics of antibacterial agents in the older population: a literature review;Expert Review of Clinical Pharmacology;2024-01-02